Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
The Pineal Gland01:02

The Pineal Gland

The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep hygiene mediates anxiety and sleep quality in adults: mediation and network analysis.

BJPsych open·2026
Same author

What Impact Does Lack of Sleep Have on Mental Health?

Brain sciences·2026
Same author

Marine life is a silent casualty of armed conflicts.

Nature·2026
Same author

Sleep health in the older adults: Architecture, circadian changes, and common sleep disorders.

Ageing research reviews·2026
Same author

Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter.

Npj biological timing and sleep·2026
Same author

Examining sleep signals at the cradle of life: can phylogenomic analysis of the Last Universal Common Ancestor (LUCA) reveal the fundamental role of sleep?

Molecular genetics and genomics : MGG·2026

Related Experiment Video

Updated: Jun 27, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Melatonin and the immune system in aging.

Daniel P Cardinali1, Ana I Esquifino, Venkataramanujan Srinivasan

  • 1Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina. dcardinali@fmed.uba.ar

Neuroimmunomodulation
|December 3, 2008
PubMed
Summary

Aging impairs immune function, increasing disease risk. Melatonin, a hormone that decreases with age, shows potential to boost the aging immune system by stimulating key immune cells and enhancing cytokine production.

More Related Videos

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
07:58

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Published on: April 16, 2012

Related Experiment Videos

Last Updated: Jun 27, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
07:58

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Published on: April 16, 2012

Area of Science:

  • Immunology
  • Endocrinology
  • Gerontology

Background:

  • Aging leads to immunosenescence, a decline in immune function.
  • Immunosenescence is linked to higher risks of cancer, infections, and degenerative diseases.
  • Both innate and adaptive immunity deteriorate with age, with decreased circulating melatonin levels observed.

Purpose of the Study:

  • To investigate the immunomodulatory effects of melatonin.
  • To explore melatonin's potential therapeutic value in enhancing immune function in aged individuals.

Main Methods:

  • Review of existing research on melatonin and immune function in aging.
  • Analysis of melatonin's effects on immune cell production (progenitor cells, natural killer cells, T cells).
  • Examination of melatonin's influence on cytokine production.

Main Results:

  • Melatonin stimulates the production of granulocyte and macrophage progenitor cells.
  • Melatonin enhances natural killer (NK) cells and CD4+ T cells while inhibiting CD8+ T cells.
  • Melatonin increases the production and release of cytokines from NK cells and T helper lymphocytes.

Conclusions:

  • Melatonin exhibits significant immunomodulatory effects relevant to aging.
  • Melatonin demonstrates potential as a therapeutic agent to counteract age-related immune decline.
  • Further research into melatonin's role could lead to interventions for age-associated diseases.